Healio

FDA approves Avlayah to treat neurologic manifestations of Hunter syndrome

The FDA has given accelerated approval to Avlayah as a treatment for neurologic manifestations of Hunter syndrome, also known ...

Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)

First new FDA-approved treatment option in nearly 20 years for families living with this rare lysosomal storage diseaseFirst FDA-approved ...
MedPage Today on MSN

FDA Signals Regulatory Flexibility With Accelerated Approval of Rare Disease Drug

Tividenofusp alfa is the first approved treatment for neurologic complications of Hunter s ...
AOL

Brain supplements have become a social media wellness trend - but are they safe to take?

Omega-3 fatty acids are essential nutrients that keep the body’s cells healthy, trigger the production of happy hormones and help slash the risk of heart disease and cancer when consumed as a part of ...
Psychiatry Advisor

FDA Approves Drug for Rare Brain Disorder, Not Autism

The FDA has not approved leucovorin for the treatment of autism, though some experts are still seeing an increase in ...
Fox News

FDA clears first at-home brain device for depression

For the first time, Americans with depression will soon be able to use a prescription brain-stimulation device at home. The approval comes from the U.S. Food and Drug Administration and marks a major ...

Rhythm's therapy becomes first FDA-approved treatment for brain damage-related obesity

By Sneha S K and Sahil Pandey March 20 (Reuters) - The U.S. Food and Drug Administration expanded the use of Rhythm ...
WBAL-TV

FDA finds little evidence that a generic drug can help people with autism

The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration officials that ...